Corrigendum to 'Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies' [Biomed. Pharmacother. 150 (2022) 112949]
التفاصيل البيبلوغرافية
العنوان:
Corrigendum to 'Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies' [Biomed. Pharmacother. 150 (2022) 112949]